Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Drug Testing and Analysis|August 2, 2022
Detection of AP-237 and synthetic cannabinoids on an infused letter sent to a German prisonerArianna Giorgetti, Pietro Brunetti, Susi Pelotti, et al.Expert Opinion on Drug Metabolism & Toxicology|January 19, 2022
Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugsGiovanna Ricci, Francesco Paolo Busardò, Filippo Gibelli, et al.Medicina (Kaunas, Lithuania)|May 21, 2020
Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing DoctorsPietro Brunetti, Simona Pichini, Roberta Pacifici, et al.Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Designer Benzodiazepines: A Review of Toxicology and Public Health RisksPietro Brunetti, Raffaele Giorgetti, Adriano Tagliabracci, et al.Drug Testing and Analysis|November 11, 2022
Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACAArianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.Pharmaceuticals (Basel, Switzerland)|October 17, 2020
Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse EffectsPietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, et al.Proteomics|May 21, 2011
A comparative MudPIT analysis identifies different expression profiles in heart compartmentsClaudio Comunian, Francesca Rusconi, Antonella De Palma, et al.Medicina (Kaunas, Lithuania)|October 23, 2021
Does the EU COVID Digital Certificate Strike a Reasonable Balance between Mobility Needs and Public Health?Gianluca Montanari Vergallo, Simona Zaami, Francesca Negro, et al.Journal of Analytical Toxicology|August 30, 2020
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and AnalogsPietro Brunetti, Filippo Pirani, Jeremy Carlier, et al.Drug Testing and Analysis|September 1, 2024
Human phase-I metabolism of three synthetic cannabinoids bearing a cumyl moiety and a cyclobutyl methyl or norbornyl methyl tail: Cumyl-CBMEGACLONE, Cumyl-NBMEGACLONE, and Cumyl-NBMINACAArianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.Pageof 3